Back to search

Article

Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells

2021-05-10

Abstract excerpt

<h4>Background</h4> Spinal cord motor neurons (MNs) from human iPS cells (iPSCs) have wide applications in disease modeling and therapeutic development for amyotrophic lateral sclerosis (ALS) and other MN-associated neurodegenerative diseases. We need highly efficient MN differentiation strategies for generating iPSC-derived disease models that closely recapitulate the genetic and phenotypic complexity of ALS. An...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8a942eaa-67ab-5780-b101-3d8f37da40fb
DOI
10.1101/2021.05.09.443325
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cellsDOI 10.1101/2021.05.09.443325
Select a neighboring publication to make it the new centre.